Possible immunoprotective and angiogenesis-promoting roles for malignant cell-derived prostasomes: A new paradigm for prostatic cancer?

Advances in Experimental Medicine and Biology

Volumn 586, Issue , 2006, Pages 107-119

  Ekdahl, Kristina Nilsson ^a   Ronquist, Gunnar ^b   Nilsson, Bo ^b   Babiker, Adil A ^b  

^a LINNAEUS UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934436839     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34134-X_8     Document Type: Conference Paper

References (50)

1. A. Jemal, T . Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer and M. J. Thun, Cancer statistics, CA Cancer J Clin 55(1), 10-30 (2005).
2. R. A. Bok and E. J. Small, Bloodborne biomolecular markers in prostate cancer development and progression, Nat Rev Cancer 2(12), 918-926 (2002).
3. G. Ronquist and M. Hedström, Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A, Biochim Biophys Acta 483(2), 483-486 (1977).
4. G. Ronquist, I. Brody, A. Gottfries and B. Stegmayr, An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic fluid, part I. Andrologia 10(4), 261-272 (1978).
5. G. Ronquist and I. Brody, The prostasome: its secretion and function in man, Biochim Biophys Acta 822(2), 203-218 (1985).
6. A. G. Utleg, E. C. Yi, T. Xie, P. Shannon, J. T. White, D. R. Goodlett, L. Hood and B. Lin, Proteomic analysis of human prostasomes, Prostate 56, 150-161 (2003).
7. G. Ronquist, I. Brody, A. Gottfries and B. Stegmayr, An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic fluid, part II. Andrologia 10(6), 427-433 (1978).
8. E. H. Oliw, R. Fabiani, L. Johansson, and G. Ronquist, Arachidonic acid 15-lipoxygenase and traces of E prostaglandins in purified human prostasomes, J Reprod Fertil 99(1) ,195-199 (1993).
9. G. Arienti, E. Carlini, R. Verdacchi, E. V. Cosmi and C. A. Palmerini. Prostasome to sperm transfer of CD13/aminopeptidase N (EC 3.4.11.2), Biochim Biophys Acta 1336(3), 533-538 (1997).
10. I. de Meester, G. Vanhoof, A. M. Lambeir and S. Scharpe S, Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5), J Immunol Methods 189(1), 99-105 (1996).
11. H. Renneberg, M. Albrecht, R. Kurek, E. Krause, F. Lottspeich, G. Aumuller and B. Wilhelm, Identification and characterization of neutral endopeptidase (EC 3. 4. 24. 11) from human prostasomes -localization in prostatic tissue and cell lines, Prostate 46(3),173-183 (2001).
12. B. Stegmayr, I. Brody and G. Ronquist, A biochemical and ultrastructural study on the endogenous protein kinase activity of secretory granule membranes of prostatic origin in human seminal plasma, J Ultrastruct Res 78(2), 206-214 (1982).
13. I. Rooney, J. Heuser, and J. Atkinson. GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanism of their binding to exogenous cells, J Clin Invest 97, 1675-1686 (1996).
14. G. A. Jarvis, J. Li, J. Hakulinen, K. A. Brady, S. Nordling, R. Dahiya and S. Meri, Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancer, Int J Cancer 71(6), 1049-1055 (1997).
15. A. A. Babiker, G. Ronquist, U. R. Nilsson and B. Nilsson, Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis, Am J Reprod Immunol 47, 183-192 (2002).
16. A.A. Babiker, B. Nilsson, G. Ronquist, L. Carlsson and K.N. Ekdahl, Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack, Prostate 62(2), 105-114 (2005).
17. B. Stegmayr and G. Ronquist, Promotive effect on human sperm progressive motility by prostasomes, Urol Res 10(5), 253-257 (1982).
18. R. Fabiani, L. Johansson, O. Lundkvist and G. Ronquist, Enhanced recruitment of motile spermatozoa by prostasome inclusion in swim-up medium, Hum Reprod 9(8), 1485-1489 (1994).
19. F. Saez, C. Motta, D. Boucher and G. Grizard, Antioxidant capacity of prostasomes in human semen, Mol Hum Reprod 4(7), 667-672 (1998).
20. G. H. Delves, A. B. Stewart, B. A. Lwaleed and A. J. Cooper, In vitro inhibition of angiogenesis by prostasomes, Prostate Cancer Prostatic Dis 8(2), 174-178 (2005).
21. A. B. Stewart, W. Anderson, G. Delves G, B. A. Lwaleed, B. Birch and A. Cooper, Prostasomes: a role in prostatic disease? BJU Int 94(7), 985-989 (2004).
22. L. Carlsson, O. Nilsson, A. Larsson, M. Stridsberg, G. Sahlén and G. Ronquist, Characteristics of human prostasomes isolated from three different sources, Prostate 54(4), 322-330 (2003).
23. G. Sahlén, A. Ahlander, A. Frost, G. Ronquist, B. J. Norlen and B. O. Nilsson, Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases, Prostate 61(3), 291-297 (2004).
24. D. Floryk, S. L. Tollaksen, C. S. Giometti and E. Huberman, Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5′-monophosphate dehydrogenase, Cancer Res 64(24), 9049-9056 (2004).
25. A. A. Babiker, B. Nilsson, G. Ronquist G and K. N. Ekdahl, Overexpression of ectoprotein kinases in prostasomes of metastatic cell origin, Prostate, in press (2006).
26. J. A. Fernández, M. J. Heeb, K. P. Radtke, and J. H. Griffin, Potent blood coagulant activity of human semen due to prostasome-bound tissue factor, Biol Reprod 56, 757-763 (1997).
27. M. F. Bernet-Camard, M. H. Coconnier, S. Hudault and A. L. Servin, Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines, Gut 38(2), 248-253 (1996).
28. S. D. Lucas, A. Karlsson-Parra, B. Nilsson, L. Grimelius, G. Akerstrom, J. Rastad and C. Juhlin, Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma, Hum Pathol 27(12), 1329-1335 (1996).
29. F. Niculescu, H. G. Rus, M. Retegan and R. Vlaicu, Persistent complement activation on tumor cells in breast cancer, Am J Pathol 140, 1039-1043 (1992).
30. G. A. Niehans, D. L. Cherwitz, N. A. Staley, D. J. Knapp and A. P. Dalmasso. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin), Am J Pathol 149(1), 129-142 (1996).
31. L. Bjorge, C. A. Vedeler, E. Ulvestad and R. Matre, Expression and function of CD59 on colonic adenocarcinoma cells, Eur J Immunol 24(7), 1597-1603 (1994).
32. M. Yamakawa, K. Yamada, T. Tsuge, H. Ohrui, T. Ogata, M. Dobashi and Y. Imai, Protection of thyroid cancer cells by complement-regulatory factors, Cancer 73(11), 2808-2817 (1994).
33. K.N. Ekdahl and B. Nilsson, Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3, Biochem J 328(2), 625-633 (1997).
34. Y. Paas, O. Bohana-Kashtan and Z. Fishelson, Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells, Immunopharmacology 42(1-3), 175-185 (1999).
35. P. Hofman, B. Hsi, S. Maine, P. Fenichel, A. Thyss and B. Rossi B, High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: A preventive mechanism of malignant tumor cells against complement attack? Breast Cancer Res Treat 34, 213-219 (1994).
36. Z. Madjd, S. Pinder, C. Paish, I. Ellis, J. Carmichael, and L. Durrand, Loss of CD59 expression in breast tumours correlates with poor survival. J Pathol 200, 633-639 (2003).
37. Z. Madjd, L. Durrand, R. Bradley, I. Spendlove, I. Ellis and S. Pinder, Loss of CD55 is associated with aggressive breast tumors, Clin Cancer Res 10, 2797-2803 (2004).
38. G. Ronquist, G. Frithz and A. Jansson, Prostasome membrane associated enzyme activities and semen parameters in men attending an infertility clinic, Urol Int 43(3), 133-138 (1988).
39. M. E. Kaighn, K. S. Narayan, Y. Ohnuki, J. F. Lechner and L. W. Jones, Establishment and characterization of a human prostatic carcinoma cell line (PC-3), Invest Urol 17(1), 16-23 (1979).
40. K. R. Stone, D. D. Mickey, H. Wunderli, G. H. Mickey and D. F. Paulson, Isolation of a human prostate carcinoma cell line (DU 145), Int J Cancer 21(3), 274-281 (1978).
41. J. S. Horoszewicz, S. S. Leong, T. M. Chu, Z. L. Wajsman, M. Friedman, L. Papsidero, U. Kim, L. S. Chai, S. Kakati, S. K. Arya and A. A. Sandberg, The LNCaP cell line - a new model for studies on human prostatic carcinoma, Prog Clin Biol Res 37, 115-132 (1980).
42. K. N. Ekdahl and B. Nilsson, Phosphorylation of plasma proteins with emphasis on complement component C3, Mol Immunol 36(4-5), 233-239 (1999).
43. P. O. Forsberg, S. C. Martin, B. Nilsson, P. Ekman, U. R. Nilsson and L. Engstrom, In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways, J Biol Chem 265(5), 2941-2946 (1990).
44. T. Hermoso, Z. Fishelson, S. I. Becker, K. Hirschberg and C. L. Jaffe, Leishmanial protein kinases phosphorylate components of the complement system, Embo J 10(13), 4061-4067 (1991).
45. P. O. Forsberg and S. C. Martin, Plasmin digestion of human fibrinogen previously phosphorylated by protein kinase C or dephosphorylated by alkaline phosphatase in vitro, Thromb Res 58(2), 119-127 (1990).
46. S. C. Martin, P. O. Forsberg and S. D. Eriksson, The effects of in vitro phosphorylation and dephosphorylation on the thrombin-induced gelation and plasmin degradation of fibrinogen, Thromb Res 61, 243-252 (1991).
47. K. N. Ekdahl, L. Rönnblom, G. Sturfelt and B. Nilsson, Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis, Arthritis Rheum 40(12), 2178-2186 (1997).
48. K. N. Ekdahl, A. A. Bengtsson, J. Andersson, G. Elgue, L. Rönnblom, G. Sturfelt and B. Nilsson, Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation, Br J Haematol 125(1), 74-78 (2004).
49. Y. Roche, D. Pasquier, J. Rambeaud, D. Seigneurin and A. Duperray, Fibrinogen mediates bladder cancer migration in an ICAM-1-dependent pathway, Thromb Haemost 89(6), 1089-1097 (2003).
50. I. Schvartz, T. Kreizman, V. Brumfeld, Z. Gechtman, D. Seger and S. Shaltiel, The PKA phosphorylation of vitronectin: effect on conformation and function, Arch Biochem Biophys 397(2), 246-252 (2002).